Become A Clinical Trial Volunteer - Touch Another Life
Uh-oh! This study is no longer available.

We're sorry, but the study or condition you’re looking for is no longer available. You can search all currently enrolling studies or contact us if you have any questions.

Type 2 Diabetes on Metformin – NAFLD Risk Study

Medical Condition

Diabetes (Type 2 Diabetes)

Facility/Clinic

PMG Research of Winston Salem

Age

18-70

Gender

Male/Female

Description

Approximately 70% of people with diabetes are thought to have some degree of nonalcoholic fatty liver disease (NAFLD), according to the National Institute of Health. 

A research study is evaluating an investigational medication for with type 2 diabetes who are at risk for developing NAFLD. This medication may help lower HbA1c levels and reduce fat accumulation in the liver.

This research study may be an option if you: 
Have type 2 diabetes and are on a stable dose of metformin only 
Have an HbA1c between 7 – 10.5%
Are willing and able to complete MRI scans and FibroScan® (liver ultrasound)
Have a Body Mass Index (BMI) between 25 - 40. Find out your BMI here http://bmicalculator.cc/ 

Other criteria apply.  Please make sure to discuss with a member of our research staff to ensure this research study is a good fit for you.

Qualified participants will receive all study-related care and study medication or placebo at no cost.

To learn more about NAFLD visit www.pmg-research.com/nash

Enrollment

Closed

Patient Commitment Duration

Approximately 5 months

Patient Compensation

Financial compensation may be provided for time and travel expenses.  

Number of visits in study

Approximately 13 clinic visits and 1 phone call

Apply for this Study Now